Kozin SV - Search Results

1

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK. Garkavtsev I, et al. Among authors: kozin sv. Nature. 2004 Mar 18;428(6980):328-32. doi: 10.1038/nature02329. Nature. 2004. PMID: 15029197

2

Perivascular nitric oxide gradients normalize tumor vasculature.

Kashiwagi S, Tsukada K, Xu L, Miyazaki J, Kozin SV, Tyrrell JA, Sessa WC, Gerweck LE, Jain RK, Fukumura D. Kashiwagi S, et al. Among authors: kozin sv. Nat Med. 2008 Mar;14(3):255-7. doi: 10.1038/nm1730. Epub 2008 Feb 17. Nat Med. 2008. PMID: 18278052

3

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK. Willett CG, et al. Among authors: kozin sv. Nat Med. 2004 Feb;10(2):145-7. doi: 10.1038/nm988. Epub 2004 Jan 25. Nat Med. 2004. PMID: 14745444 Free PMC article. Clinical Trial.

4

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.

Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK. Tong RT, et al. Among authors: kozin sv. Cancer Res. 2004 Jun 1;64(11):3731-6. doi: 10.1158/0008-5472.CAN-04-0074. Cancer Res. 2004. PMID: 15172975

5

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. Winkler F, et al. Among authors: kozin sv. Cancer Cell. 2004 Dec;6(6):553-63. doi: 10.1016/j.ccr.2004.10.011. Cancer Cell. 2004. PMID: 15607960 Free article.

6

Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors.

Kozin SV, Winkler F, Garkavtsev I, Hicklin DJ, Jain RK, Boucher Y. Kozin SV, et al. Cancer Res. 2007 Jun 1;67(11):5076-82. doi: 10.1158/0008-5472.CAN-06-3664. Cancer Res. 2007. PMID: 17545583

7

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.

Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, Stylianopoulos T, Mousa AS, Han X, Adstamongkonkul P, Popović Z, Huang P, Bawendi MG, Boucher Y, Jain RK. Chauhan VP, et al. Among authors: kozin sv. Nat Commun. 2013;4:2516. doi: 10.1038/ncomms3516. Nat Commun. 2013. PMID: 24084631 Free PMC article.

8

Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Kozin SV, Duda DG, Munn LL, Jain RK. Kozin SV, et al. J Natl Cancer Inst. 2012 Jun 20;104(12):899-905. doi: 10.1093/jnci/djs239. Epub 2012 May 9. J Natl Cancer Inst. 2012. PMID: 22572994 Free PMC article. Review.

9

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation.

Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, Duda DG. Kozin SV, et al. Cancer Res. 2010 Jul 15;70(14):5679-85. doi: 10.1158/0008-5472.CAN-09-4446. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631066 Free PMC article.

10

Is vasculogenesis crucial for the regrowth of irradiated tumours?

Kozin SV, Duda DG, Munn LL, Jain RK. Kozin SV, et al. Nat Rev Cancer. 2011 Jun 24;11(7):532. doi: 10.1038/nrc2007-c1. Nat Rev Cancer. 2011. PMID: 21701514 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page